Evidence map›Paper›PMID 41884139›Full record

ReviewFrontiers in medicine2026

Current perspectives and updates on transfusion strategies in critically ill anemic patients.

Haowei Yang, Feifei Li, Zhenghua Zhu, Lining Si, Yi Liu, Songbei Li, Yang Liu, Hua Cai, Yuxin Fan, Yuxuan Zhang and 3 more

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Haowei YangSchool of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Feifei LiSchool of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Zhenghua ZhuDepartment of Respiratory and Critical Care Medicine, The Second People's Hospital of Kunming, Kunming, China.
Lining SiDepartment of Critical Care Medicine, Affiliated Hospital of Qinghai University, Xining, China.
Yi LiuDepartment of Respiratory and Critical Care Medicine, The Second People's Hospital of Kunming, Kunming, China.
Songbei LiDepartment of Intensive Care Unit, Affiliated Hospital of Chengdu University, Chengdu, China.
Yang LiuDepartment of Critical Care Medicine, Sichuan Provincial People's Hospital Pujiang Hospital/Pujiang County People's Hospital, Chengdu, China.
Hua CaiDepartment of Critical Care Medicine, Sichuan Provincial People's Hospital Pujiang Hospital/Pujiang County People's Hospital, Chengdu, China.
Yuxin FanSchool of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yuxuan ZhangSchool of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Chun Pan *Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Sen Lu *Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Hongli He *Department of Critical Care Medicine, Sichuan Provincial People's Hospital Pujiang Hospital/Pujiang County People's Hospital, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anemia is a frequently encountered condition in critically ill patients, and red blood cell transfusion serves as a critical therapeutic intervention aimed at restoring hemoglobin levels and improving tissue oxygenation. However, the optimal threshold for transfusion remains a subject of controversy, particularly regarding the comparison between restrictive (Hb 7-9 g/dL) and liberal (Hb > 9 g/dL) strategies. However, we should also consider a third option. This method focuses on the individual patient. Doctors adjust care based on the patient's specific symptoms and other health problems. The selection of the appropriate strategy is contingent upon specific clinical conditions, such as sepsis, acute coronary syndrome, or neurological injury. Current evidence and clinical guidelines predominantly favor a restrictive transfusion in hemodynamically stable patients, whereas a liberal strategy may benefit those with underlying cardiovascular disease. This review synthesizes recent trial data and guideline recommendations to facilitate evidence-based and individualized transfusion decision-making in the ICU, aiming to optimize the balance between risks and benefits across diverse critical care settings.

Indexed as

blood transfusionintensive care unitsliberal transfusionrestrictive transfusiontransfusion threshold

Identifiers

PMID41884139
PMCPMC13008982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.